Evidence map›Paper›PMID 40644526›Full record

ArticlePLoS biology2025

Structural elucidation of the haptoglobin-hemoglobin clearance mechanism by macrophage scavenger receptor CD163.

Ching-Shin Huang, Hui Wang, Joshua B R White, Oksana Degtjarik, Cindy Huynh, Kristoffer Brannstrom, Mark T Horn, Stephen P Muench, William S Somers, Javier Chaparro-Riggers and 2 more

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Cryo-EM provides insight into how thebioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Macrophages on demand: How tissue trauma shapes their role.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ching-Shin HuangBioMedicine Design, Pfizer, Inc., Cambridge, Massachusetts, United States of America.ORCID 0000-0002-6435-9309
Hui WangBioMedicine Design, Pfizer, Inc., La Jolla, California, United States of America.
Joshua B R WhiteSchool of Molecular and Cellular Biology, Faculty of Biological Sciences & Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
Oksana DegtjarikSchool of Molecular and Cellular Biology, Faculty of Biological Sciences & Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
Cindy HuynhBioMedicine Design, Pfizer, Inc., La Jolla, California, United States of America.
Kristoffer BrannstromBioMedicine Design, Pfizer, Inc., La Jolla, California, United States of America.
Mark T HornBioMedicine Design, Pfizer, Inc., La Jolla, California, United States of America.
Stephen P MuenchSchool of Biomedical Sciences, Faculty of Biological Sciences & Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
William S SomersBioMedicine Design, Pfizer, Inc., Cambridge, Massachusetts, United States of America.
Javier Chaparro-RiggersBioMedicine Design, Pfizer, Inc., La Jolla, California, United States of America.
Laura LinBioMedicine Design, Pfizer, Inc., Cambridge, Massachusetts, United States of America.
Lidia MosyakBioMedicine Design, Pfizer, Inc., Cambridge, Massachusetts, United States of America.

Funding

Pfizer, Inc., Cambridge, MA, USA
6 · The paper itself

Abstract

Intravascular hemolysis releases hemoglobin into the bloodstream, which can damage vascular and renal tissues due to its oxidative nature. Circulating haptoglobin acts as a primary defense by binding to free hemoglobin, forming a haptoglobin-hemoglobin (HpHb) complex that is then recognized and cleared by the CD163 scavenger receptor on macrophages. While the function and structure of HpHb complex are mostly well-defined, the molecular mechanism underlying its interaction with CD163 remains unclear. Here we report the cryo-electron microscopy structures of human CD163 in its unliganded state and in its complex with HpHb. These structures reveal that CD163 functions as a trimer, forming a composite binding site at its center for one protomer of the dimeric HpHb, resulting in a 3:1 binding stoichiometry. In the unliganded state, CD163 can also form a trimer, but in an autoinhibitory configuration that occludes the ligand binding site. Widespread electrostatic interactions mediated by calcium ions are pivotal in both pre-ligand and ligand-bound receptor assemblies. This calcium-dependent mechanism enables CD163/HpHb complexes to assemble and, once internalized, disassemble into individual components upon reaching the endosome, where low calcium and lower pH conditions prevail. Collectively, this study elucidates the molecular mechanism by which CD163-mediated endocytosis efficiently clears different isoforms of HpHb.

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticHaptoglobinsHemoglobinsReceptors, Cell SurfaceBinding SitesCalciumCD163 AntigenCryoelectron MicroscopyHumansMacrophagesModels, MolecularProtein BindingProtein MultimerizationReceptors, ScavengerAntigens, CDAntigens, Differentiation, MyelomonocyticCalciumCD163 Antigenhaptoglobin-hemoglobin complexHaptoglobinsHemoglobinsReceptors, Cell SurfaceReceptors, Scavenger

Identifiers

PMID40644526
PMCPMC12273918

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.